ASX - By Stock
|
IMM |
Re:
Ann: Immutep letter to ineligible shareholders
|
|
macenroc
|
4 |
2.2K |
9 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
4
|
2.2K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Capital Raising Presentation
|
|
macenroc
|
8 |
3.7K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
8
|
3.7K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Capital Raising Presentation
|
|
macenroc
|
8 |
3.7K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
8
|
3.7K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces Ph 3 clinical trial collaboration with MSD
|
|
macenroc
|
11 |
6.2K |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
11
|
6.2K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
What have we got?
|
|
macenroc
|
42 |
27K |
4 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
42
|
27K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Marc do your job!
|
|
macenroc
|
42 |
19K |
1 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
42
|
19K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Marc do your job!
|
|
macenroc
|
42 |
19K |
17 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
42
|
19K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
macenroc
|
743 |
338K |
29 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
743
|
338K
|
29
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
macenroc
|
743 |
338K |
4 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
743
|
338K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
macenroc
|
743 |
338K |
0 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
743
|
338K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
macenroc
|
743 |
338K |
1 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
743
|
338K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change in substantial holding
|
|
macenroc
|
18 |
6.4K |
1 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
18
|
6.4K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change in substantial holding
|
|
macenroc
|
18 |
6.4K |
1 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
18
|
6.4K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
macenroc
|
743 |
338K |
1 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
743
|
338K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Interesting article in Saturday Telegraph relating to Keytruda.
|
|
macenroc
|
13 |
7.4K |
0 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
13
|
7.4K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Interesting article in Saturday Telegraph relating to Keytruda.
|
|
macenroc
|
13 |
7.4K |
8 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
13
|
7.4K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Interesting article in Saturday Telegraph relating to Keytruda.
|
|
macenroc
|
13 |
7.4K |
1 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
13
|
7.4K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
macenroc
|
743 |
338K |
8 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
743
|
338K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
12 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
8 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
8 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: New Biomarker Data from TACTI-002 trial in 1st line NSCLC
|
|
macenroc
|
6 |
4.0K |
18 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
6
|
4.0K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Results of Meeting
|
|
macenroc
|
20 |
8.3K |
0 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
20
|
8.3K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Results of Meeting
|
|
macenroc
|
20 |
8.3K |
8 |
28/10/23 |
28/10/23 |
ASX - By Stock
|
20
|
8.3K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Results of Meeting
|
|
macenroc
|
20 |
8.3K |
2 |
28/10/23 |
28/10/23 |
ASX - By Stock
|
20
|
8.3K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
8 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep reports promising data from INSIGHT-003 trial
|
|
macenroc
|
10 |
5.4K |
18 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
10
|
5.4K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Webcast slides for new Efti clinical data in 1st line NSCLC
|
|
macenroc
|
25 |
10K |
4 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
25
|
10K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Webcast slides for new Efti clinical data in 1st line NSCLC
|
|
macenroc
|
25 |
10K |
8 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
25
|
10K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Webcast slides for new Efti clinical data in 1st line NSCLC
|
|
macenroc
|
25 |
10K |
11 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
25
|
10K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
4 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
13 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep granted US patent for IMP761 agonist LAG-3 antibody
|
|
macenroc
|
21 |
9.0K |
1 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
21
|
9.0K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
macenroc
|
37 |
12K |
3 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
37
|
12K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: A$80 million fully underwritten equity raising
|
|
macenroc
|
57 |
25K |
0 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
57
|
25K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
macenroc
|
743 |
338K |
3 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
743
|
338K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
macenroc
|
743 |
338K |
1 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
743
|
338K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
macenroc
|
743 |
338K |
1 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
743
|
338K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
macenroc
|
743 |
338K |
3 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
743
|
338K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
16 |
20/05/23 |
20/05/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Initiation of Phase 2 Trial for Efti in Soft Tissue Sarcoma
|
|
macenroc
|
11 |
5.4K |
10 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
11
|
5.4K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
0 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
0 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
0 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
2 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
8 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
14 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
14
|
|
ASX - By Stock
|
IMM |
Re:
a current prediction
|
|
macenroc
|
128 |
770K |
4 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
128
|
770K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
7 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
macenroc
|
2.7K |
1.1M |
3 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
3
|
|